Literature DB >> 2378476

Identification and cloning of a 27-kDa Coxiella burnetii immunoreactive protein.

L R Hendrix1, J E Samuel, L P Mallavia.   

Abstract

Patients with acute Q fever develop Coxiella burnetii-specific antibody, and chronic disease patients often develop extremely high levels of C. burnetii-specific antibody. Antibody-reactive LPS has been well characterized, but only a few immunoreactive proteins have been identified. An immunoreactive ca. 62-kDa protein has been cloned, sequenced, and shown to be related to an Escherichia coli heat-shock protein. A ca. 27-kDa immunoreactive outer membrane protein(s) has also been identified. We have begun characterizing C. burnetii immunoreactive proteins by gene-cloning methods. A gene bank of total C. burnetii Nine Mile phase 1 (acute strain) DNA was created using the lambda vector EMBL3. This bank was screened for plaques which reacted with E. coli-pre-absorbed rabbit antisera specific for purified, Nine Mile C. burnetii whole cells. Twenty-three immunoreactive plaques were identified from a screening of 3000 plaques. Twenty-two plaques produced a ca. 60-65-kDa immunoreactive protein. One plaque produced a ca. 27-kDa immunoreactive protein, as well as a ca. 60-65-kDa immunoreactive protein. Phage extracts of this plaque were used to enrich the antisera to produce a ca. 27-kDa-specific antisera. This enriched sera reacted with a ca. 27-kDa protein in all C. burnetii isolates tested, comprising isolates from both chronic and acute strains. The DNA contained in the immunoreactive clone was C. burnetii-specific, as shown by DNA hybridization. We are currently subcloning the ca. 27-kDa protein-coding region for sequencing to determine if this gene encodes the previously identified ca. 27-kDa immunodominant protein. This protein may ultimately have both diagnostic and vaccinogenic potential.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2378476     DOI: 10.1111/j.1749-6632.1990.tb42263.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  9 in total

Review 1.  Molecular biology of rickettsiae.

Authors:  H H Winkler
Journal:  Eur J Epidemiol       Date:  1991-05       Impact factor: 8.082

Review 2.  Genetics of rickettsiae.

Authors:  L P Mallavia
Journal:  Eur J Epidemiol       Date:  1991-05       Impact factor: 8.082

Review 3.  Q fever.

Authors:  M Maurin; D Raoult
Journal:  Clin Microbiol Rev       Date:  1999-10       Impact factor: 26.132

4.  Genetic diversity of the Q fever agent, Coxiella burnetii, assessed by microarray-based whole-genome comparisons.

Authors:  Paul A Beare; James E Samuel; Dale Howe; Kimmo Virtaneva; Stephen F Porcella; Robert A Heinzen
Journal:  J Bacteriol       Date:  2006-04       Impact factor: 3.490

5.  Characterization and protective effect of a 29 kDa protein isolated from Coxiella burnetii by detergent Empigen BB.

Authors:  M Lukácová; E Gajdosová; L Skultéty; E Kovácová; J Kazár
Journal:  Eur J Epidemiol       Date:  1994-04       Impact factor: 8.082

6.  Cloning and sequencing of Coxiella burnetii outer membrane protein gene com1.

Authors:  L R Hendrix; L P Mallavia; J E Samuel
Journal:  Infect Immun       Date:  1993-02       Impact factor: 3.441

7.  Identification of CD4+ T cell epitopes in C. burnetii antigens targeted by antibody responses.

Authors:  Chen Chen; Courtney Dow; Peng Wang; John Sidney; Amanda Read; Allen Harmsen; James E Samuel; Bjoern Peters
Journal:  PLoS One       Date:  2011-03-15       Impact factor: 3.240

8.  Potential serodiagnostic markers for Q fever identified in Coxiella burnetii by immunoproteomic and protein microarray approaches.

Authors:  Xiaolu Xiong; Xile Wang; Bohai Wen; Stephen Graves; John Stenos
Journal:  BMC Microbiol       Date:  2012-03-16       Impact factor: 3.605

9.  Soluble antigens derived from Coxiella burnetii elicit protective immunity in three animal models without inducing hypersensitivity.

Authors:  Anthony E Gregory; Erin J van Schaik; Alycia P Fratzke; Kasi E Russell-Lodrigue; Christina M Farris; James E Samuel
Journal:  Cell Rep Med       Date:  2021-12-06
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.